Stockreport

Beyond Elevidys: Unveiling The Competitive Landscape Of Duchenne's Muscular Dystrophy [Seeking Alpha]

Catalent, Inc.  (CTLT) 
Last catalent, inc. earnings: 2/3 07:30 am Check Earnings Report
US:NYSE Investor Relations: investor.catalent.com
PDF Several companies including PFE, CAPR, RGNX, SLDB, VRTX, have DMD gene-therapy product candidates in their pipeline. Thus, Elevidys's monopoly could be under a threat. [Read more]